Sign in

    Unitedhealth Group Inc (UNH)

    Business Description

    UnitedHealth Group is a diversified health and well-being company that operates through two main businesses: Optum and UnitedHealthcare. The company aims to enhance health system performance by improving access, affordability, outcomes, and experiences . UnitedHealth Group offers a range of health benefits and services through its various segments, including care delivery, analytics, technology, and pharmacy care . The company's significant revenue drivers are its UnitedHealthcare and Optum segments, which collectively contribute to its overall financial performance .

    1. UnitedHealthcare - Offers a comprehensive range of health benefits and is divided into three sub-segments:

      • UnitedHealthcare Employer & Individual - Provides health benefit plans and services to employers and individuals.
      • UnitedHealthcare Medicare & Retirement - Offers health and well-being services to individuals aged 65 and older.
      • UnitedHealthcare Community & State - Delivers health benefits and services to state programs and communities.

    2. Optum - Comprises three segments focused on different aspects of health services:

      • Optum Health - Focuses on care delivery and management to improve health outcomes.
      • Optum Insight - Provides analytics and technology services to enhance healthcare operations.
      • Optum Rx - Offers pharmacy care services to optimize medication management and delivery.

    Q3 2024 Summary

    Initial Price$506.75July 1, 2024
    Final Price$583.30October 1, 2024
    Price Change$76.55
    % Change+15.11%

    What went well

    • OptumHealth is experiencing strong performance, driven by strategic portfolio refinement focusing on care delivery businesses and value-based care models. Increased outreach from payers seeking enduring partners in capitated arrangements positions the company for diversified growth across multiple lines of business.
    • UnitedHealthcare's Medicare Advantage business is well-positioned, with a long-term planning view and a focus on benefit stability for consumers. Leveraging new technologies like AI and machine learning is providing efficiencies that help offset headwinds, suggesting potential for continued growth despite a dynamic environment.
    • UnitedHealth Group is maintaining disciplined capital deployment, focusing on its five growth pillars: benefit design, value-based care, technology-led opportunities, pharmacy businesses, and financial services. A shift towards a more consumer-centric experience, with investments in technology and consumerization, underpins strong returns and future growth opportunities.

    What went wrong

    • UnitedHealth is facing higher costs due to aggressive hospital coding practices, with some entities increasing coding intensity factors by more than 20%, resulting in an unnecessary additional cost burden.
    • The Medicaid business is experiencing financial pressure due to a timing mismatch between increased member acuity and lagging state rate updates, which have not yet caught up to the higher health care needs and increased behavioral health costs of the remaining members after redeterminations.
    • UnitedHealth anticipates stepping out for 2025 more conservatively than typical, with the upper end of their EPS guidance around $30 per share, partially due to the concurrent impact of CMS Medicare rate cuts and the Inflation Reduction Act, potentially signaling lower earnings growth.

    Q&A Summary

    1. 2025 Earnings Guidance
      Q: Why is 2025 EPS growth lower at 8%?
      A: Due to government funding reductions and continued cost pressures, especially in Medicare Advantage, we expect 2025 EPS to grow about 8%, which acknowledges external pressures but preserves long-term investments ( ).

    2. Medical Cost Pressures
      Q: How are rising costs impacting your MLR?
      A: Three factors—specialty drug utilization increases due to the IRA, provider coding intensity, and Medicaid redetermination timing mismatches—have equally impacted our MLR this quarter ( , ).

    3. Medicare Advantage Strategy
      Q: How important is MA growth to your strategy?
      A: Medicare Advantage remains crucial, but we're diversifying growth across five pillars, including value-based care and technology, aiming for stability amid a dynamic MA landscape ( ).

    4. OptumHealth Margins
      Q: What drove margin improvements in OptumHealth?
      A: Portfolio refinements and focus on care delivery improved margins. We're exiting non-core businesses to strengthen our value-based care position ( , ).

    5. OptumInsight Recovery
      Q: How is OptumInsight performing post-cyberattack?
      A: Recovery is progressing well; some revenue disruption will carry into 2025. We're leveraging AI innovations to accelerate growth in our core business ( ).

    6. Medicaid Redeterminations
      Q: How are redeterminations affecting Medicaid margins?
      A: The impact from redeterminations is subsiding, but funding rates haven't yet caught up with current cost trends. We're working with state partners to address this ( ).

    7. Capital Deployment Priorities
      Q: What are your capital deployment plans for 2025?
      A: We'll focus on our five growth pillars—benefits, value-based care, technology, pharmacy, and financial services—aiming for strong shareholder returns ( ).

    8. Commercial Business Performance
      Q: Are cost pressures affecting your commercial segment?
      A: The commercial business remains strong with effective cost management. The pressures impacting MLR are not affecting this segment ( ).

    9. Cost Reduction Sustainability
      Q: Will cost reductions continue into 2025?
      A: Yes, we're committed to sustainable cost reductions to offset funding pressures and will remain disciplined in cost management, especially in Optum ( ).

    10. Investments in AI and Technology
      Q: How will AI investments impact growth?
      A: AI is accelerating innovation, particularly in OptumInsight, transforming products and creating differentiated offerings to drive growth ( , ).

    Key Metrics

    View all financials →
    Revenue by Segment - in Millions of USDFY 2013Q1 2014Q2 2014Q3 2014Q4 2014FY 2014Q1 2015Q2 2015Q3 2015Q4 2015FY 2015Q1 2016Q2 2016Q3 2016Q4 2016FY 2016Q1 2017Q2 2017Q3 2017Q4 2017FY 2017Q1 2018Q2 2018Q3 2018Q4 2018FY 2018Q1 2019Q2 2019Q3 2019Q4 2019FY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024
    UnitedHealthcare70,46870,23169,85370,808281,36075,35773,86674,853
    - Employer & Individual----76,494---
    - Medicare & Retirement----129,862---
    - Community & State----75,004---
    - Global--------
    Optum54,05956,34456,73759,495226,63561,05262,87963,925
    - Optum Health23,00423,91723,86424,53495,31926,73127,05025,917
    - Optum Insight4,4964,6744,9774,78518,9324,5024,5434,931
    - Optum Rx27,41828,64628,85731,166116,08730,83532,41534,207
    - Optum Eliminations(859)(893)(961)-(3,703)(1,016)(1,129)(1,130)
    Eliminations-(33,672)--(136,373)(36,613)(37,890)(37,958)
    Corporate and Eliminations--------
    Premiums72,78672,47472,33973,228290,82777,98876,89777,442
    Products10,26710,65110,35411,31142,58311,90912,21112,631
    Services8,0808,6638,6718,70934,1238,8888,7509,104
    Investment and Other Income7981,1159971,1794,0891,0119971,643
    Total Revenue91,93192,90392,36194,427371,62299,79698,855100,820
    KPIs - Metric (Unit: Million Adjusted Scripts)FY 2013Q1 2014Q2 2014Q3 2014Q4 2014FY 2014Q1 2015Q2 2015Q3 2015Q4 2015FY 2015Q1 2016Q2 2016Q3 2016Q4 2016FY 2016Q1 2017Q2 2017Q3 2017Q4 2017FY 2017Q1 2018Q2 2018Q3 2018Q4 2018FY 2018Q1 2019Q2 2019Q3 2019Q4 2019FY 2019Q1 2020Q2 2020Q3 2020Q4 2020FY 2020Q1 2021Q2 2021Q3 2021Q4 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024
    Fulfilled Adjusted Scripts378381383400-395399407
    Metric (Unit: Million People)Q1 2023Q2 2023Q3 2023Q4 2023-Q1 2024Q2 2024Q3 2024
    ---------------------------------------------------------------------------------------------------------
    Served People103103103103-104104104

    Executive Team

    NamePositionStart DateShort Bio
    Andrew WittyChief Executive OfficerFebruary 2021Andrew Witty has served as the CEO of UnitedHealth Group since February 2021. He was previously CEO of Optum and President of UnitedHealth Group. Before joining UNH, he was CEO of GlaxoSmithKline .
    Dirk McMahonPresident and Chief Operating OfficerFebruary 2021Dirk McMahon has served as President and COO of UnitedHealth Group since February 2021. He was previously CEO of UnitedHealthcare and President and COO of Optum .
    John RexExecutive Vice President and Chief Financial OfficerJune 2016John Rex has served as EVP and CFO of UnitedHealth Group since June 2016. He was previously EVP and CFO of Optum and a Managing Director at JP Morgan .
    Rupert BondyExecutive Vice President, Chief Legal Officer and Corporate SecretaryMarch 2022Rupert Bondy has served as EVP and Chief Legal Officer of UnitedHealth Group since March 2022 and Corporate Secretary since April 2022. He was previously SVP, General Counsel, and Corporate Secretary at Reckitt Benckiser Group .
    Erin McSweeneyExecutive Vice President and Chief People OfficerMarch 2022Erin McSweeney has served as EVP and Chief People Officer of UnitedHealth Group since March 2022. She was previously chief of staff to UNH's Office of the Chief Executive and EVP and Chief HR Officer at Optum .
    Thomas RoosSenior Vice President and Chief Accounting OfficerAugust 2015Thomas Roos has served as SVP and Chief Accounting Officer of UnitedHealth Group since August 2015. He was previously a Partner at Deloitte & Touche LLP .
    Brian ThompsonChief Executive Officer of UnitedHealthcareApril 2021Brian Thompson served as CEO of UnitedHealthcare from April 2021 until his passing in December 2024. He held various leadership roles within UnitedHealthcare, including CEO of government programs and CEO of Medicare & Retirement .
    Chris ZaettaExecutive Vice President and Chief Legal OfficerJune 2024Christopher R. Zaetta serves as EVP and Chief Legal Officer at UnitedHealth Group. He is listed as Chief Legal Officer in a Form 3 filing dated June 14, 2024 .

    Questions to Ask Management

    1. Given the simultaneous pressures from CMS Medicare rate cuts, the Inflation Reduction Act impacts, and increased specialty drug costs, how specifically do you expect these factors to affect your Medicare Advantage margins in 2025, and what mitigation strategies are in place to address them?

    2. Your initial 2025 EPS guidance suggests approximately 8% growth, which is below your long-term target of 13–16%; can you elaborate on the key factors driving this conservative outlook and your confidence in returning to the target range in subsequent years?

    3. With Medicaid redeterminations leading to higher acuity among remaining members and lagging state rate adjustments, how are you managing the timing mismatch in Medicaid funding, and when do you anticipate alignment between rates and current care activity levels?

    4. You mentioned aggressive hospital coding intensity increases adding unnecessary costs; what specific actions are you taking to address this upcoding issue, and how soon do you expect to see these efforts positively impact your cost structure?

    5. While investing heavily in AI and technology modernization for 2025, can you detail how these investments will contribute to earnings growth and operational efficiency in the near term, especially amid existing margin pressures?

    Share Repurchase Program

    Program DetailsProgram 1
    Approval DateJune 2024
    End Date/DurationNo expiration date
    Total additional amount35 million shares
    Remaining authorization42 million shares
    DetailsOptimizes capital structure and offsets share-based awards

    Past Guidance

    Q3 2024 Earnings Call

    • Issued Period: Q3 2024
    • Guided Period: FY 2024 and FY 2025
    • Guidance:
      1. Adjusted Earnings Outlook for 2024: Narrowed to $27.50 to $27.75 per share .
      2. Impact of Change Healthcare Disruption: Estimated at $0.75 per share for 2024, with a reduction expected in 2025 .
      3. 2025 Earnings Per Share Guidance: Upper end of the range around $30 .

    Q2 2024 Earnings Call

    • Issued Period: Q2 2024
    • Guided Period: FY 2024
    • Guidance:
      1. Full Year Adjusted EPS: Affirmed at $27.50 to $28.00 .
      2. Medical Care Ratio: Expected at the upper end of the range, excluding certain effects .
      3. Cyberattack Impact: Estimated at $1.90 to $2.05 per share, with direct costs and business disruption impacts specified .
      4. OptumHealth Margins: Target of 7.7% to 8% .
      5. Medical Loss Ratio (MLR): Core MLR expected at 84.5%, GAAP MLR at 84.8% .

    Q1 2024 Earnings Call

    • Issued Period: Q1 2024
    • Guided Period: FY 2024
    • Guidance:
      1. Full Year Adjusted EPS: Expected at $27.50 to $28.00 .
      2. Impact of Change Healthcare Cyberattack: Estimated at $1.15 to $1.35 per share, with direct costs and business disruption impacts detailed .
      3. Medical Care Ratio (MCR): First quarter MCR was 84.3%, with specific impacts noted .
      4. Claims Reserves: Additional $800 million due to potential cyberattack effects .

    Q4 2023 Earnings Call

    • Issued Period: Q4 2023
    • Guided Period: FY 2024
    • Guidance:
      1. Adjusted EPS Growth Rate: Long-term growth rate of 13% to 16% .
      2. Medicare Advantage Enrollment: Growth of 450,000 to 550,000 lives .
      3. Care Ratio Outlook: 84%, plus or minus 50 basis points .
      4. Optum Health Margin Targets: 7.7% to 8.0% .
      5. Optum Health Patient Engagement: Serving at least another 750,000 patients under value-based care .